|D045169||Severe Acute Respiratory Syndrome NIH||0.04|
|D018352||Coronavirus Infections NIH||0.04|
There is one clinical trial.
Our society is going through an unprecedented situation: the COVID 19 Pandemic is forcing many populations, worldwide, into confinement for their own protection. The very characteristics of this confinement and of the disease (isolation, potential severity of the illness, being psychologically unprepared for such a circumstance) have a significant impact on one's psyche, like emotional disorders -anxiety/depression-, difficulties when returning to normal life, vicarious traumas… Confinement is paradoxical in as although well-intended to protect the individual, it leads to the isolation of the individual. This paradox is destabilizing one's feelings, because when the investigators feel the need for protection and reassurance, the investigators are left alone and feel abandoned. The investigators therefore understand that this confinement framework is in essence a situation that might revive unresolved deprivation situations from the childhood. How to react in front of this upsurge in anxiety? Strategies used may include, among others, escape in the imaginary through numerical tools or others, and /or going to the actual characterized by deviant sexual behaviours. The investigators know in fact that certain moments, like anxiety, depression, boredom, psychological unrest are propicious for acting, for violent sexual offenders. The investigators therefore pay extra attention to our patients in such periods favoring these kinds of trouble. This study will enable us to understand if the confinement associated with COVID 19 has generated anxiety that lead sexual offenders or individuals with paraphilic disorders to engage into deviant fantasies or, potentially sexual activities.
Description: Lickert scale from 1 to 10Measure: Impact of confinement on deviant fantasies Time: through study completion, an average of 1 year
Description: Likert scale from 0 to 10Measure: Intensity of deviant fantasies Time: through study completion, an average of 1 year
Description: Likert scale from 0 to 10Measure: Frequency of deviant fantasies Time: through study completion, an average of 1 year
Description: Box to be chacked by the patient: exhibition, voyeurism, pedophilia, sadomasochism, crossdressing, raptophiliaMeasure: Paraphilic type impacted Time: through study completion, an average of 1 year
Description: Number given by the patientMeasure: Occurrence of sexual act Time: through study completion, an average of 1 year
Description: Did you use internet : yes or noMeasure: Access mode for deviant fantasies Time: through study completion, an average of 1 year
Description: box yes or no Was support different? Did you use remote consultation? How did you like it?Measure: Use of support during confinement Time: through study completion, an average of 1 year
Description: HAD Hospital Anxiety And Depression Scale The HAD scale is an instrument for detecting anxiety and depressive disorders. It has 14 listed items from 0 to 3. Seven questions relate to anxiety (total A) and seven others to the depressive dimension (total D), two scores are obtained (maximum score for each score = 21). - 7 or less: absence of symptoms - 8 to 10: doubtful symptomatology - 11 and more: certain symptomatology.Measure: Evaluating anxiety/depression level Time: through study completion, an average of 1 year
Data processed on December 13, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports